We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+14.55%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$24.6M
Cap. Flow
-$44M
Cap. Flow %
-4.18%
Top 10 Hldgs %
44.97%
Holding
105
New
25
Increased
29
Reduced
11
Closed
33

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$33.2M
2
BDX icon
Becton Dickinson
BDX
+$17.7M
3
ELV icon
Elevance Health
ELV
+$15.9M
4
TMO icon
Thermo Fisher Scientific
TMO
+$14.3M
5
DGX icon
Quest Diagnostics
DGX
+$13.7M

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$28.2M
2
ABBV icon
AbbVie
ABBV
+$24.6M
3
CRL icon
Charles River Laboratories
CRL
+$17.6M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.4M
5
ISRG icon
Intuitive Surgical
ISRG
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 95.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$21.4B
$104M 9.87%
1,550,000
+250,000
+19% +$9.7M
THC icon
2
Tenet Healthcare
THC
$20.5B
$66.5M 6.32%
500,000
+75,000
+18% +$9.03M
CYTK icon
3
Cytokinetics
CYTK
$10.5B
$54.2M 5.15%
1,000,000
+550,000
+122% +$33.2M
BSX icon
4
Boston Scientific
BSX
$69.5B
$50.1M 4.76%
650,000
+50,000
+8% +$3.66M
ELV icon
5
Elevance Health
ELV
$81.5B
$43.3M 4.12%
80,000
+30,000
+60% +$15.9M
BPMC
6
DELISTED
Blueprint Medicines
BPMC
$36.6M 3.48%
340,000
+130,000
+62% +$13M
NVS icon
7
Novartis
NVS
$297B
$31.9M 3.03%
300,000
+75,000
+33% +$7.53M
LBPH
8
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$29.7M 2.82%
1,100,000
+125,000
+13% +$2.47M
MRK icon
9
Merck
MRK
$322B
$29.1M 2.76%
235,000
– –
HUM icon
10
Humana
HUM
$43.7B
$28M 2.66%
75,000
+15,000
+25% +$5.06M
EHC icon
11
Encompass Health
EHC
$11B
$25.7M 2.45%
300,000
-50,000
-14% -$4.2M
UHS icon
12
Universal Health Services
UHS
$10.2B
$24M 2.28%
130,000
+5,000
+4% +$885K
IONS icon
13
CALL
Ionis Pharmaceuticals
IONS
$8.6B
$23.8M 2.26%
+500,000
New +$20.5M
NARI
14
DELISTED
Inari Medical, Inc. Common Stock
NARI
$19.3M 1.83%
400,000
+200,000
+100% +$8.86M
VERA icon
15
Vera Therapeutics
VERA
$2.3B
$18.1M 1.72%
500,000
+140,000
+39% +$5.55M
CRNX icon
16
Crinetics Pharmaceuticals
CRNX
$8.84B
$17.9M 1.7%
400,000
+75,000
+23% +$3.46M
BDX icon
17
Becton Dickinson
BDX
$45.6B
$17.5M 1.67%
+75,000
New +$17.7M
CI icon
18
Cigna
CI
$73.7B
$16.5M 1.57%
50,000
+10,000
+25% +$3.45M
TARS icon
19
Tarsus Pharmaceuticals
TARS
$2.58B
$16M 1.52%
590,000
– –
KRYS icon
20
Krystal Biotech
KRYS
$10.1B
$15.6M 1.48%
85,000
+5,000
+6% +$839K
ACLX
21
DELISTED
Arcellx
ACLX
$15.2M 1.44%
275,000
+20,000
+8% +$1.09M
ICLR icon
22
Icon
ICLR
$12.6B
$14.1M 1.34%
45,000
– –
EW icon
23
Edwards Lifesciences
EW
$49.6B
$13.9M 1.32%
+150,000
New +$13.3M
TMO icon
24
Thermo Fisher Scientific
TMO
$213B
$13.8M 1.31%
+25,000
New +$14.3M
DGX icon
25
Quest Diagnostics
DGX
$25.7B
$13.7M 1.3%
+100,000
New +$13.7M
1
2 3 4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Integral Health Asset Management held 105 positions worth $1.05B, down 2.3% from $1.08B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management withdrew a net $44M in Q2 2024, closing 33 positions and reducing 11 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $28.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 95% a quarter earlier.

Against the trend, Integral Health Asset Management opened a new position in Becton Dickinson worth $17.5M.

  • Integral Health Asset Management's largest Q2 2024 buy was Becton Dickinson: 75,000 shares worth $17.5M.
  • Integral Health Asset Management added most to Cytokinetics in Q2 2024, an estimated $33.2M increase.
  • Integral Health Asset Management's biggest Q2 2024 reduction was Intuitive Surgical, cutting an estimated $15.9M.
  • Integral Health Asset Management fully exited Walgreens Boots Alliance in Q2 2024, selling an estimated $28.2M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $1.05B portfolio in Q2 2024.
  • Integral Health Asset Management opened 25 new positions and closed 33 in Q2 2024.
  • Integral Health Asset Management's portfolio value fell 2.3% quarter-over-quarter to $1.05B.

Based on Integral Health Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.